Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Esteban

Showing results (11-20 of 222) with videos related to

Pageof 23
Sort By:
Expert Review of Gastroenterology & Hepatology|September 16, 2014
Hepatitis C virus genotype 3: a genotype that is not 'easy-to-treat'Maria Buti, Rafael Esteban
Clinics in Liver Disease|August 27, 2011
1990-2010: two decades of interferon-based therapyMaria Buti, Rafael Esteban
Journal of Hepatology|January 8, 2004
Entecavir, FTC, L-FMAU, LdT and othersMaria Buti, Rafael Esteban
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Patient experience in HCV therapy: what really mattersMaría Buti, Rafael Esteban
Annals of Hepatology|November 17, 2007
Long-term outcome after interferon therapy in patients with chronic hepatitis CMaria Buti, Rafael Esteban
Gastroenterology|September 30, 2015
Therapy with direct-acting antivirals for genotype 3 patients: interferon's last gasp?Rafael Esteban, Maria Buti
Liver International : Official Journal of the International Association for the Study of the Liver|January 4, 2012
Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?Mitchell L Shiffman, Rafael Esteban
Gastroenterologia Y Hepatologia|August 5, 2014
[Hepatic encephalopathy]Juan Córdoba, Rafael Esteban Mur
Revista Espanola De Enfermedades Digestivas|January 29, 2021
The Screening Guidelines for Hepatitis C Virus Infection as a milestone in the path towards hepatitis C virus eliminationJosé Luis Calleja Panero, Rafael Esteban
Clinics in Liver Disease|October 1, 2021
Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral TherapyMaria Buti, Mar Riveiro-Barciela, Rafael Esteban
Pageof 23

Showing results (11-20 of 222) with videos related to

Sort By:
Pageof 23
Expert Review of Gastroenterology & Hepatology|September 16, 2014
Hepatitis C virus genotype 3: a genotype that is not 'easy-to-treat'Maria Buti, Rafael Esteban
Clinics in Liver Disease|August 27, 2011
1990-2010: two decades of interferon-based therapyMaria Buti, Rafael Esteban
Journal of Hepatology|January 8, 2004
Entecavir, FTC, L-FMAU, LdT and othersMaria Buti, Rafael Esteban
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Patient experience in HCV therapy: what really mattersMaría Buti, Rafael Esteban
Annals of Hepatology|November 17, 2007
Long-term outcome after interferon therapy in patients with chronic hepatitis CMaria Buti, Rafael Esteban
Gastroenterology|September 30, 2015
Therapy with direct-acting antivirals for genotype 3 patients: interferon's last gasp?Rafael Esteban, Maria Buti
Liver International : Official Journal of the International Association for the Study of the Liver|January 4, 2012
Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?Mitchell L Shiffman, Rafael Esteban
Gastroenterologia Y Hepatologia|August 5, 2014
[Hepatic encephalopathy]Juan Córdoba, Rafael Esteban Mur
Revista Espanola De Enfermedades Digestivas|January 29, 2021
The Screening Guidelines for Hepatitis C Virus Infection as a milestone in the path towards hepatitis C virus eliminationJosé Luis Calleja Panero, Rafael Esteban
Clinics in Liver Disease|October 1, 2021
Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral TherapyMaria Buti, Mar Riveiro-Barciela, Rafael Esteban
Pageof 23